Detalhe da pesquisa
1.
Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases.
BMC Cancer
; 22(1): 660, 2022 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710393
2.
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.
Int J Mol Sci
; 21(21)2020 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33153070
3.
Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice.
BMC Cancer
; 19(1): 960, 2019 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31619203
4.
Effects of Chemotherapy in Patients with Concomitant Aortic Aneurysm and Malignant Disease.
Ann Vasc Surg
; 45: 268.e13-268.e20, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28739458
5.
Dose-dense nonpegylated liposomal Doxorubicin and docetaxel combination in breast cancer: dose-finding study.
Oncologist
; 20(2): 109-10, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25601964
6.
Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx).
BMC Med
; 11: 59, 2013 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23497191
7.
Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease.
BMC Med
; 10: 135, 2012 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23136868
8.
Intensive multidisciplinary treatment strategies and patient resilience to challenge long-term survival in metastatic colorectal cancer: a case report in real life and clinical practice.
Ann Transl Med
; 9(12): 1027, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34277827
9.
"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study.
BMC Cancer
; 10: 567, 2010 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-20958992
10.
Pharmacogenomic Assessment of Patients with Colorectal Cancer and Potential Treatments.
Pharmgenomics Pers Med
; 13: 601-617, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33235483
11.
Toxicity Syndromes, Patient-Related Clinical Indicator of Toxicity Burden Induced by Intensive Triplet Chemotherapy-Based Regimens in Gastrointestinal Cancers With Metastatic Disease.
Front Oncol
; 10: 172, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32154172
12.
Relevance of Pharmacogenomics and Multidisciplinary Management in a Young-Elderly Patient With KRAS Mutant Colorectal Cancer Treated With First-Line Aflibercept-Containing Chemotherapy.
Front Oncol
; 10: 1155, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32850329
13.
Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study.
J Cancer Res Clin Oncol
; 146(5): 1273-1290, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32088781
14.
Precision oncotherapy based on liquid biopsies in multidisciplinary treatment of unresectable recurrent rectal cancer: a retrospective cohort study.
J Cancer Res Clin Oncol
; 146(1): 205-219, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31620896
15.
Hypoxic pelvic perfusion with cisplatin and mitomycin C in multidisciplinary palliative treatment of patients with unresectable recurrent rectal cancer: a retrospective study.
Minerva Chir
; 74(4): 304-312, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31062943
16.
Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers.
Ther Adv Med Oncol
; 11: 1758835919846421, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31205502
17.
Multidisciplinary palliation for unresectable recurrent rectal cancer: hypoxic pelvic perfusion with mitomycin C and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort study.
Oncotarget
; 10(39): 1-13, 2019 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31231460
18.
Dose-finding study of intensive weekly alternating schedule of docetaxel, 5-fluorouracil, and oxaliplatin, FD/FOx regimen, in metastatic gastric cancer.
Oncotarget
; 9(29): 20339-20350, 2018 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29755655
19.
Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study.
Oncotarget
; 9(61): 31861-31876, 2018 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30159128
20.
KRAS and 2 rare PI3KCA mutations coexisting in a metastatic colorectal cancer patient with aggressive and resistant disease.
Hum Pathol
; 74: 178-182, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29409955